Literature DB >> 15279345

Perianal blockage with 0.5% bupivacaine for postoperative pain relief in hemorrhoidectomy.

Siriwan Jirasiritham1, Kamthorn Tantivitayatan, Sopon Jirasiritham.   

Abstract

UNLABELLED: Hemorrhoidectomy can be done in many positions under many anesthetic techniques as an ambulatory surgery. Post-procedural pain is frequently severe enough to delay home discharge. A combination between preincisional local anesthetics and general anesthesia looks attractive in terms of preemptive analgesia and starting time of surgery. The study aimed to compare anesthetic time, pain-free period and pain relief in patients with and without 0.5% plain bupivacaine infiltration after mask inhalation, total intravenous anesthesia or endotracheal tube general anesthesia. MATERIAL AND
METHOD: 142 patients were randomized into control (C) and study (S) groups with n = 70 and 72 respectively. Patient characteristics in both groups were: age 40.45 +/- 13.03 VS 37.48 +/- 13.63 years old, BW 59.77 +/- 11.19 VS 58.80 +/- 9.76 kg, male:female 31/39 VS 43/29, PS 1/2/3/E = 48/19/1/2 VS 53/15/3/1 for C and S respectively. All underwent surgery in lithotomy under ET/TIVA/mask: 53/13/4 VS 22/27/23 and anesthetic time was 49.02 +/- 18.04 VS 33.33 +/- 10.31 min (p < 0.05).
RESULTS: Pain-free periods in C and S were 204.44 +/- 878.07 and 540 +/- 298.03 min with median times of 57.5 (n = 67) VS 560 (n = 58) min. Pain severity in S was mainly none or mild degree while in C it was moderate or severe, apparently when analysed in subgroups of ET and TIVA. Analgesic requirements were statistically more in group C.
CONCLUSION: Better postoperative pain relief could be accomplished by preincisional 0.5% plain bupivacaine infiltration after general anesthesia. The technique helped relax anal muscles for surgical ease and avoided patient discomfort in case of a prolonged procedure. Preemptive analgesia and key pain management were discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279345

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

Review 1.  Perioperative Management of the Ambulatory Anorectal Surgery Patient.

Authors:  Darcy Shaw; Charles A Ternent
Journal:  Clin Colon Rectal Surg       Date:  2016-03

2.  [Pain management after hemorrhoidectomy. Patient-controlled analgesia vs conventional pain therapy].

Authors:  E Hancke; M Lampinski; K Suchan; K Völke
Journal:  Chirurg       Date:  2013-07       Impact factor: 0.955

Review 3.  Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site.

Authors:  DeeDee Hu; Erol Onel; Neil Singla; William G Kramer; Admir Hadzic
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

Review 4.  Nanotherapeutic-directed approaches to analgesia.

Authors:  Liudmila L Mazaleuskaya; Vladimir R Muzykantov; Garret A FitzGerald
Journal:  Trends Pharmacol Sci       Date:  2021-04-19       Impact factor: 17.638

5.  Liposome bupivacaine for postsurgical pain in an obese woman with chronic pain undergoing laparoscopic gastrectomy: a case report.

Authors:  Peter M Bertin
Journal:  J Med Case Rep       Date:  2014-01-22

6.  The effect of local injections of bupivacaine plus ketamine, bupivacaine alone, and placebo on reducing postoperative anal fistula pain: a randomized clinical trial.

Authors:  Alireza Kazemeini; Mojgan Rahimi; Mohammad Sadegh Fazeli; Seyedeh Adeleh Mirjafari; Hamid Ghaderi; Kamal Fani; Mohammad Forozeshfard; Marzieh Matin
Journal:  ScientificWorldJournal       Date:  2014-12-03

7.  Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia.

Authors:  Sergio D Bergese; Sonia Ramamoorthy; Gary Patou; Kenneth Bramlett; Stephen R Gorfine; Keith A Candiotti
Journal:  J Pain Res       Date:  2012-05-01       Impact factor: 3.133

8.  Bupivacaine Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine Administered After Cesarean Birth.

Authors:  Hiba J Mustafa; Henry L Wong; Mahmoud Al-Kofahi; Malinda Schaefer; Ashwin Karanam; Michael M Todd
Journal:  Obstet Gynecol       Date:  2020-07       Impact factor: 7.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.